TRAIL limits excessive host immune responses in bacterial meningitis

被引:57
作者
Hoffmann, Olaf
Priller, Josef
Prozorovski, Timour
Schulze-Topphoff, Ulf
Baeva, Nevena
Lunemann, Jan D.
Aktas, Orhan
Mahrhofer, Cordula
Stricker, Sarah
Zipp, Frauke
Weber, Joerg R.
机构
[1] Charite Univ Med Berlin, Dept Cell Biol & Neurobiol, Ctr Anat, D-10117 Berlin, Germany
[2] Charite Univ Med Berlin, Dept Neurol, D-10117 Berlin, Germany
[3] Charite Univ Med Berlin, Lab Mol Psychiat, D-10117 Berlin, Germany
[4] Charite Univ Med Berlin, Dept Neuroimmunol, D-10117 Berlin, Germany
关键词
D O I
10.1172/JCI30356
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Apart from potential roles in anti-tumor surveillance, the TNF-related apoptosis-inducing ligand (TRAIL) has important regulatory functions in the host immune response. We studied antiinflammatory effects of endogenous and recombinant TRAIL (rTRAIL) in experimental meningitis. Following intrathecal application of pneumococcal cell wall, a TLR2 ligand, we found prolonged inflammation, augmented clinical impairment, and increased apoptosis in the hippocampus of TRAIL(-/-) mice. Administration of rTRAIL into the subarachnoid space of TRAIL(-/-) mice or reconstitution of hematopoiesis with wild-type bone marrow cells reversed these effects, suggesting an autoregulatory role of TRAIL within the infiltrating leukocyte population. Importantly, intrathecal application of rTRAIL in wild-type mice with meningitis also decreased inflammation and apoptosis. Moreover, patients suffering from bacterial meningitis showed increased intrathecal synthesis of TRAIL. Our findings provide what we believe is the first evidence that TRAIL may act as a negative regulator of acute CNS inflammation. The ability of TRAIL to modify inflammatory responses and to reduce neuronal cell death in meningitis suggests that it may be used as a novel antiinflammatory agent in invasive infections.
引用
收藏
页码:2004 / 2013
页数:10
相关论文
共 56 条
[41]   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression [J].
Song, KM ;
Chen, YG ;
Göke, R ;
Wilmen, A ;
Seidel, C ;
Göke, A ;
Hilliard, B ;
Chen, YH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) :1095-1103
[42]   Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development [J].
Takeda, K ;
Smyth, MJ ;
Cretney, E ;
Hayakawa, Y ;
Kayagaki, N ;
Yagita, H ;
Okumura, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (02) :161-169
[43]   EFFECTS OF AMPICILLIN AND CORTICOSTEROIDS ON BRAIN WATER-CONTENT, CEREBROSPINAL-FLUID PRESSURE, AND CEREBROSPINAL-FLUID LACTATE LEVELS IN EXPERIMENTAL PNEUMOCOCCAL MENINGITIS [J].
TAUBER, MG ;
KHAYAMBASHI, H ;
SANDE, MA .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :528-534
[44]   Corticosteroids for everyone with meningitis? [J].
Tunkel, AR ;
Scheld, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1613-1615
[45]   REDUCTION OF INFLAMMATION, TISSUE-DAMAGE, AND MORTALITY IN BACTERIAL-MENINGITIS IN RABBITS TREATED WITH MONOCLONAL-ANTIBODIES AGAINST ADHESION-PROMOTING RECEPTORS OF LEUKOCYTES [J].
TUOMANEN, EI ;
SAUKKONEN, K ;
SANDE, S ;
CIOFFE, C ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :959-968
[46]   Corticosteroids for acute bacterial meningitis [J].
van de Beek, D. ;
de Gans, J. ;
McIntyre, P. ;
Prasad, K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)
[47]   Cognitive impairment in adults with good recovery after bacterial meningitis [J].
van de Beek, D ;
Schmand, B ;
de Gans, J ;
Weisfelt, M ;
Vaessen, H ;
Dankert, J ;
Vermeulen, M .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (07) :1047-1052
[48]   Reprogramming the host response in bacterial meningitis: How best to improve outcome? [J].
van der Flier, M ;
Geelen, SPM ;
Kimpen, JLL ;
Hoepelman, IM ;
Tuomanen, EI .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (03) :415-+
[49]   EVALUATION OF VANCOMYCIN FOR THERAPY OF ADULT PNEUMOCOCCAL MENINGITIS [J].
VILADRICH, PF ;
GUDIOL, F ;
LINARES, J ;
PALLARES, R ;
SABATE, I ;
RUFI, G ;
ARIZA, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) :2467-2472
[50]   TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis [J].
Wandinger, KP ;
Lünemann, JD ;
Wengert, O ;
Bellmann-Strobl, J ;
Aktas, O ;
Weber, A ;
Grundström, E ;
Ehrlich, S ;
Wernecke, KD ;
Volk, HD ;
Zipp, F .
LANCET, 2003, 361 (9374) :2036-2043